A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Testosterone replacement treatment is the most effective way of treating hypogonadism in men.
Acrux has a propriety testosterone replacement product, Testosterone MD-Lotion and this study
will evaluate pharmacokinetics of testosterone MD-Lotion formulations.The study will also
assess safety of the product.